Upgrade to SI Premium - Free Trial

Sapiens Reports Fourth Quarter and Full Year 2018 Financial Results

February 26, 2019 5:43 AM

HOLON, Israel, Feb. 26, 2019 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) and (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) and (TASE: FORT), today announced its financial results for the fourth quarter and full year ended December 31, 2018.

Sapiens International Corporation Logo

Summary Results for Fourth Quarter 2018 (USD in millions, except per share data)

GAAP

% Change

Non-GAAP

% Change

December 31, 2018

December 31, 2017

December 31, 2018

December 31, 2017

Revenue

73.3

71.6

2.4%

73.4

72.4

1.4%

Operating Income

6.6

1.1

500%

10.8

9.1

18.7%

Operating Margin

9.0%

1.6%

740 bps

14.8 %

12.5%

230 bps

Net income

3.8

3.4

11.8%

7.9

6.0

31.7 %

Diluted EPS

$0.07

$0.07

-

$0.16

$0.12

33 %

Summary Results for Full Year 2018 (USD in millions, except per share data)

GAAP

% Change

Non-GAAP

% Change

December 31, 2018

December 31, 2017

December 31, 2018

December 31, 2017

Revenue

289.7

269.2

7.6%

290.3

272.0

6.7 %

Operating Income

23.0

1.0

2200%

39.6

23.1

71.4 %

Operating Margin

7.9%

0.4%

750 bps

13.6 %

8.5 %

510 bps

Net income

14.0

0.6

2233%

28.3

15.4

83.8 %

Diluted EPS

$0.28

$0.01

2700%

$0.56

$0.31

80.6 %

"Sapiens had a strong finish to 2018, closing out the year with another quarter of growth and profitability by executing on our key objectives. In the fourth quarter, on a Non-GAAP basis, revenue totaled $73.4 and operating margin improved by 230 basis points to 14.8%. We continued the expansion of our P&C businesses in key markets. We managed costs and aligned our R&D investments with our growth segments, which increased operating profit and fueled almost 31.7% increase in net income in the quarter," stated Roni Al-Dor. president and CEO, Sapiens.

"In 2018, Sapiens made significant progress on our key objectives, which drove outstanding financial performance for the year. For the full year, on a Non-GAAP basis, revenue increased 6.7% driven by new deals, acquisitions and by expanding our business with existing customers as illustrated by double-digit growth in our EMEA P&C business. Meanwhile, we have fully integrated our Stream and Adaptik operations, which has accelerated the growth of our U.S. P&C business. Also, we made meaningful headway in our L&A business, creating a stronger foundation for growth in 2019. Synergies and cost controls produced significant expansion in operating margin, which increased over 500 basis points to 13.6%, exceeding the high end of our annual guidance.

"The expansion of our solutions and service offerings from both product development initiatives and acquisitions, as well as our collaborations with InsurTech groups to complement our core offerings, helped us win new business and earn increased industry recognition. To support all of these offerings, we are building a new account management executive team to evolve our customer support model into global customer success teams, focused on cross-selling, upselling and increasing awareness of all of our capabilities and products." continued Mr. Al-Dor.

Mr. Al-Dor concluded: "We have recently launched a new brand architecture to reflect our evolution into a unified global provider of innovative digital insurance solutions. With an improved competitive position as a one-stop-shop for insurance software solutions and an enhanced product and service platform, we're forecasting 2019 full year non-GAAP revenues in the range of $318 to $323 million, with non-GAAP operating margins in the range of 15.2% to 15.6%."

Quarterly Results Conference Call

Management will host a conference call and webcast on February 26, 2019 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-668-9141; International: +972-3-918-0609; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/

If you are unable to join live, a replay of the call will be accessible until March 5, 2019, as follows: North America: 1-888-295-2634; International: +972-3-925-5918

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, and non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, redeemable non-controlling interests, loss on sales of Marketable Securities and tax adjustment regarding non-GAAP adjustments, as well as the impact of one-time adjustment to our deferred taxes as a result of the U.S. Tax Cuts and Job act 2017.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation is a leading global provider of software solutions for the insurance industry, with a 35-year track record of delivering to more than 400 organizations. The company offers software platforms, solutions and services, including a full digital suite, to satisfy the needs of property and casualty/general insurers, and life, pension and annuity providers. Sapiens also services the reinsurance, workers' compensation, financial and compliance, and decision management markets.

The company's portfolio includes policy administration, billing and claims, underwriting, illustration and electronic application. The digital suite features customer and agent portals, and a business intelligence platform. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2017, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Year ended

December 31,

December 31,

2018

2017

2018

2017

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

73,311

71,600

289,707

269,194

Cost of revenue

45,428

45,776

180,138

175,678

Gross profit

27,883

25,824

109,569

93,516

Operating expenses:

Research and development, net

8,284

8,427

34,414

31,955

Selling, marketing, general and administrative

13,016

16,265

52,133

60,559

Total operating expenses

21,300

24,692

86,547

92,514

Operating income

6,583

1,132

23,022

1,002

Financial expense, net

829

1,000

3,957

3,010

Taxes on income and other expenses (tax benefit), net

1,922

(3,301)

5,065

(2,564)

Net income

3,832

3,433

14,000

556

Attributable to non-controlling interest

80

(157)

215

(189)

Attributed to redeemable non-controlling interest

-

43

-

43

Adjustment to redeemable non-controlling interest

-

350

-

350

Net income attributable to Sapiens' shareholders

3,752

3,197

13,785

352

Basic earnings per share

0.08

0.07

0.28

0.01

Diluted earnings per share

0.07

0.06

0.28

0.01

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

49,920

49,325

49,827

49,170

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,210

50,032

50,106

49,926

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Year ended

December 31,

December 31,

2018

2017

2018

2017

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

73,433

72,448

290,297

272,003

Cost of revenue

42,113

42,931

167,353

165,336

Gross profit

31,320

29,517

122,944

106,667

Operating expenses:

Research and development, net

9,666

9,663

39,574

37,522

Selling, marketing, general and administrative

10,805

10,795

43,810

46,032

Total operating expenses

20,471

20,458

83,384

83,554

Operating income

10,849

9,059

39,560

23,113

Financial expense, net

829

1,000

3,957

2,780

Taxes on Income and other expenses, net

2,114

2,033

7,325

4,940

Net income

7,906

6,026

28,278

15,393

Attributable to non-controlling interest

80

(115)

215

(147)

Net income attributable to Sapiens' shareholders

7,826

6,141

28,063

15,540

Basic earnings per share

0.16

0.12

0.56

0.32

Diluted earnings per share

0.16

0.12

0.56

0.31

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

49,920

49,325

49,827

49,170

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,210

50,032

50,106

49,926

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

Three months ended

Year ended

December 31,

December 31,

2018

2017

2018

2017

(unaudited)

(unaudited)

(unaudited)

(unaudited)

GAAP revenue

73,311

71,600

289,707

269,194

Valuation adjustment on acquired deferred revenue

122

848

590

2,809

Non-GAAP revenue

73,433

72,448

290,297

272,003

GAAP gross profit

27,883

25,824

109,569

93,516

Valuation adjustment on acquired deferred revenue

122

848

590

2,809

Amortization of capitalized software

1,247

1,270

4,859

4,824

Amortization of other intangible assets

2,068

1,575

7,926

5,518

Non-GAAP gross profit

31,320

29,517

122,944

106,667

GAAP operating income

6,583

1,132

23,022

1,002

Gross profit adjustments

3,437

3,693

13,375

13,151

Capitalization of software development

(1,382)

(1,236)

(5,160)

(5,567)

Amortization of other intangible assets

926

489

3,293

1,725

Stock-based compensation

472

655

1,942

2,035

Compensation related to acquisition and acquisition-related costs

813

144

3,088

2,685

Restructuring and cost reduction plan

-

4,182

-

8,082

Non-GAAP operating income

10,849

9,059

39,560

23,113

GAAP net income attributable to Sapiens' shareholders

3,752

3,197

13,785

352

Operating income adjustments

4,266

7,927

16,538

22,111

Adjustment to redeemable non-controlling interest

-

350

-

-

350

Loss on sales of Marketable Securities

-

-

-

230

Tax and other

(192)

(5,333)

(2,260)

(7,503)

Non-GAAP net income attributable to Sapiens' shareholders

7,826

6,141

28,063

15,540

Summary of NON-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)

Three months ended

Year ended

December 31,

December 31,

2018

2017

2018

2017

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenues

73,433

100%

72,448

100%

290,297

100%

272,003

100%

Gross profit

31,320

42.7%

29,517

40.7%

122,944

42.4%

106,667

39.2%

Operating profit

10,849

14.8%

9,059

12.5%

39,560

13.6%

23,113

8.5%

Net income to shareholders

7,826

10.7%

6,141

8.5%

28,063

9.7%

15,540

5.7%

Adjusted EBITDA

11,797

16.1%

10,076

13.9%

43,344

14.9%

26,935

9.9%

Basic earnings per share

0.16

0.12

0.56

0.32

Diluted earnings per share

0.16

0.12

0.56

0.31

Non-GAAP Revenues by Geographic Breakdown

U.S. dollars in thousands

Q4 2018

Q3 2018

Q2 2018

Q1 2018

Q4 2017

North America

34,974

36,734

34,606

31,035

31,580

Europe

30,850

30,611

32,518

34,479

29,789

Asia Pacific

3,140

3,480

3,305

3,439

3,817

South Africa

4,469

2,412

2,113

2,132

7,262

Total

73,433

73,237

72,542

71,085

72,448

Adjusted EBITDA Calculation

U.S. dollars in thousands

Three months ended

Year ended

December 31,

December 31,

2018

2017

2018

2017

GAAP operating profit

6,583

1,132

23,022

1,002

Non-GAAP adjustments:

Amortization of capitalized software

1,247

1,270

4,859

4,824

Amortization of other intangible assets

2,994

2,064

11,219

7,243

Capitalization of software development

(1,382)

(1,236)

(5,160)

(5,567)

Stock-based compensation

472

655

1,942

2,035

Compensation related to acquisition and acquisition-related costs

813

144

3,088

2,685

Restructuring and cost reduction plan

-

4,182

-

8,082

Valuation adjustment on acquired deferred revenue

122

848

590

2,809

Non-GAAP operating profit

10,849

9,059

39,560

23,113

Depreciation

948

1,017

3,784

3,822

Adjusted EBITDA

11,797

10,076

43,344

26,935

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

December 31,

December 31,

2018

2017

(unaudited)

(unaudited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

64,628

71,467

Trade receivables, net and unbilled receivables

59,159

53,226

Other receivables and prepaid expenses

6,224

6,280

Total current assets

130,011

130,973

LONG-TERM ASSETS

Property and equipment, net

8,515

10,695

Severance pay fund

4,699

4,547

Goodwill and intangible assets, net

231,348

223,729

Other long-term assets

4,292

3,675

Total long-term assets

248,854

242,646

TOTAL ASSETS

378,865

373,619

LIABILITIES AND EQUITY

CURRENT LIABILITIES

Trade payables

6,149

7,044

Current maturities of Series B Debentures

9,898

-

Accrued expenses and other liabilities

46,999

46,612

Deferred revenue

18,759

16,513

Total current liabilities

81,805

70,169

LONG-TERM LIABILITIES

Series B Debentures, net of current maturities

68,577

78,281

Deferred tax liabilities

11,681

9,171

Other long-term liabilities

8,696

8,271

Accrued severance pay

5,622

5,500

Total long-term liabilities

94,576

101,223

REDEEMABLE NON-CONTROLLING INTEREST

-

1,353

EQUITY

202,484

200,874

TOTAL LIABILITIES AND EQUITY

378,865

373,619

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

For the year ended December 31,

2018

2017

(unaudited)

(unaudited)

Cash flows from operating activities:

Net income

14,000

556

Reconciliation of net income to net cash provided by operating activities:

Depreciation and amortization

19,862

15,871

Amortization of premium, accrued interest and loss on sales of marketable securities

-

509

Stock-based compensation related to options issued to employees

1,942

2,035

Net changes in operating assets and liabilities, net of amount acquired:

Trade receivables

(7,588)

(5,253)

Deferred tax assets

(1,567)

(8,840)

Other operating assets

509

3,688

Trade payables

(1,870)

(1,388)

Other operating liabilities

20

858

Deferred revenues

2,349

1,249

Severance pay

43

(37)

Net cash provided by operating activities

27,700

9,248

Cash flows from investing activities:

Purchase of property and equipment

(1,914)

(2,622)

Proceeds from sales of marketable securities

-

35,369

Payments for business acquisition, net of cash acquired

(18,507)

(100,381)

Capitalized software development costs

(5,160)

(5,567)

Net cash used in investing activities

(25,581)

(73,201)

Cash flows from financing activities:

Proceeds from employee stock options exercised

895

2,453

Distribution of dividend

(9,978)

(9,851)

Repayment of loans

(237)

(56)

Issuance of debenture, net

-

78,229

Payments of contingent considerations

(61)

(766)

Dividend to non-controlling interest

(47)

-

Net cash provided by (used in) financing activities

(9,428)

70,009

Effect of exchange rate changes on cash and cash equivalents

470

4,503

Increase (decrease) in cash and cash equivalents

(6,839)

10,559

Cash and cash equivalents at the beginning of period

71,467

60,908

Cash and cash equivalents at the end of period

64,628

71,467

Debentures Covenants

As of December 31, 2018, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $200 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) bellow 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to 6.97%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to 0.35.

Investors and Media Contact

Yaffa Cohen-IfrahChief Marketing Officer and Head of Corporate CommunicationsSapiens InternationalU.S. Mobile: +1 201-250-9414Mobile: +972 54-9099039Email: [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/sapiens-reports-fourth-quarter-and-full-year-2018-financial-results-300802033.html

SOURCE Sapiens International Corporation

Categories

Press Releases

Next Articles